News

The global continuous positive airway pressure devices market size is anticipated to reach USD 2.62 billion by 2030, growing at a CAGR of 5.45% during the forecast period, according to a new report by ...
I can report that because of the fact that ... evaluation and setup across every therapy mode that ResMed offers, including CPAP, APAP, bilevel S, bilevel ST, as well as adaptive servo ventilation ...
ResMed has a minority stake in Nyxoah who are developing a neurostimulation implant to treat OSA. Although we see little near-term risk from this therapy due to the higher cost and invasive surgery ...
Resmed says that U.S. Customs and Border Protection has confirmed that its devices will continue to be exempt from tariffs ...
However, Oppenheimer analysts caution that GLP-1 medications could present a longer-term challenge to ResMed’s continuous positive airway pressure (CPAP) device business. InvestingPro data ...
Resmed Inc. RMD recently launched its home sleep ... treating OSA with continuous positive airway pressure (CPAP) therapy can significantly reduce the risk of death. NightOwl makes it easy to ...
However, an estimated 80% of cases (23.5 million) remain undiagnosed, according to the Obstructive Sleep Apnea (OSA) National Indicator Report ... CPAP versus not using CPAP can literally be a matter ...
Noise level: Our pick for the best quiet CPAP machine is the Luna G3, but you'll want to make sure that whichever model you ...
Intuitive secured a single port robot clearance, Resmed bought sleep testing facility Virtuox, and Precision Neuroscience ...